Mice treated with anti-CD4 or anti-CD8 antibody at time of infection and 1 day after demonstrated 100% survival up to day 16 post-infection compared to 0% survival for PBS treated FVB mice (Figure 7a). This evidence concerns the gene CD8A and infection.